Insider Notice: BWX Technologies 4,571-Share Sale Filed Under Rule 144

Rhea-AI Filing Summary

BWX Technologies, Inc. (BWXT) Form 144 notice reports a proposed sale of 4,571 shares of common stock through Charles Schwab & Co., Inc. with an approximate sale date of 09/04/2025. The filer acquired these shares on 08/29/2025 by restricted stock lapse from BWX Technologies, Inc. and lists the nature of payment as equity compensation. The aggregate market value of the proposed sale is shown as $743,556.00 against 91,398,740 shares outstanding. The form states there were no securities sold by the filer in the past three months and includes the required representation that the filer is unaware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Minor insider sale disclosed: 4,571 shares from restricted stock lapse, executed via Charles Schwab, not preceded by recent sales.

The filing documents a routine Form 144 notification for a small block of shares acquired by restricted stock vesting and intended for sale. The $743,556 aggregate value is small relative to the company's 91.4 million outstanding shares, indicating limited potential market impact. The disclosure meets Rule 144 procedural requirements and confirms no other sales in the prior three months.

Corporate Governance Expert

TL;DR Compliance-focused disclosure: insider documents planned sale and attests to absence of undisclosed material information.

This Form 144 appears procedural: the filer notes acquisition by restricted stock lapse and states the sale will be handled by a broker. The representation regarding material adverse information is standard and the absence of recent sales simplifies aggregation rules. No governance concerns or material red flags are evident from the notice alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	4571	743556.00	91398740	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2025	Restricted Stock Lapse	BWX Technologies, Inc.			4571	08/29/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BWXT Form 144 disclose about the proposed sale?

The notice discloses a proposed sale of 4,571 common shares via Charles Schwab with an approximate sale date of 09/04/2025 and an aggregate market value of $743,556.00.

How were the shares acquired according to the filing?

The filer acquired the 4,571 shares on 08/29/2025 through a restricted stock lapse from BWX Technologies, Inc., and payment is listed as equity compensation.

Does the filing report any securities sold by the filer in the past three months?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is handling the proposed sale?

The broker named is Charles Schwab & Co., Inc., located at 3000 Schwab Way, Westlake, TX 76262, and the securities exchange is listed as NYSE.

What representation does the filer make about material information?

By signing the notice the filer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.